CEACAM5 and neoplasm: Additionally, in this study, we also discovered that the expression of circulating miR-141 in plasma had a clinically satisfactory degree of specificity and sensitivity with an AUC of 0.894, which presented a greater advantage than the AUC values obtained from conventional tumor biomarkers for GBC, such as CEA, CA125 and CA19-9.